Stefania Napolitano

Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge

Christine M. Parseghian, Jonathan M. Loree, Van K. Morris et al. · Annals of Oncology · 2018 · 240 citations · Full text

Medicine, Cancer Biology, Oncology +17

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With <i>RAS</i> Wild-type Metastatic Colorectal Cancer

Erika Martinelli, Giulia Martini, Vincenzo Famiglietti et al. · JAMA Oncology · 2021 · 185 citations · Full text

Medicine, Oncology, Pharmacology +17

Increased TGF-α as a Mechanism of Acquired Resistance to the Anti-EGFR Inhibitor Cetuximab through EGFR–MET Interaction and Activation of MET Signaling in Colon Cancer Cells

Teresa Troiani, Erika Martinelli, Stefania Napolitano et al. · Clinical Cancer Research · 2013 · 145 citations · Full text

Medicine, Oncology, Pharmacology +17

Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1000 consecutive clinical cases

Francesco Fiorentino, Fiorina Caiazzo, Stefania Napolitano et al. · Prenatal Diagnosis · 2011 · 109 citations

Medicine, Genetics, Obstetrics +16

Primary and Acquired Resistance of Colorectal Cancer Cells to Anti-EGFR Antibodies Converge on MEK/ERK Pathway Activation and Can Be Overcome by Combined MEK/EGFR Inhibition

Teresa Troiani, Stefania Napolitano, Donata Vitagliano et al. · Clinical Cancer Research · 2014 · 103 citations

Medicine, Oncology, Pharmacology +17